169 related articles for article (PubMed ID: 34685577)
1. Co-Expression of CD34, CD90, OV-6 and Cell-Surface Vimentin Defines Cancer Stem Cells of Hepatoblastoma, Which Are Affected by Hsp90 Inhibitor 17-AAG.
Lee-Theilen M; Hadhoud JR; Volante G; Fadini DD; Eichhorn J; Rolle U; Fiegel HC
Cells; 2021 Sep; 10(10):. PubMed ID: 34685577
[TBL] [Abstract][Full Text] [Related]
2. Hepatoblastoma Cancer Stem Cells Express PD-L1, Reveal Plasticity and Can Emerge upon Chemotherapy.
Lee-Theilen M; Fadini DD; Hadhoud JR; van Dongen F; Kroll G; Rolle U; Fiegel HC
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497307
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines.
Wang P; Gao Q; Suo Z; Munthe E; Solberg S; Ma L; Wang M; Westerdaal NA; Kvalheim G; Gaudernack G
PLoS One; 2013; 8(3):e57020. PubMed ID: 23469181
[TBL] [Abstract][Full Text] [Related]
5. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma.
Yamashita T; Honda M; Nakamoto Y; Baba M; Nio K; Hara Y; Zeng SS; Hayashi T; Kondo M; Takatori H; Yamashita T; Mizukoshi E; Ikeda H; Zen Y; Takamura H; Wang XW; Kaneko S
Hepatology; 2013 Apr; 57(4):1484-97. PubMed ID: 23174907
[TBL] [Abstract][Full Text] [Related]
6. HSP90 inhibitor 17-AAG selectively eradicates lymphoma stem cells.
Newman B; Liu Y; Lee HF; Sun D; Wang Y
Cancer Res; 2012 Sep; 72(17):4551-61. PubMed ID: 22751135
[TBL] [Abstract][Full Text] [Related]
7. Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancer.
Connor EV; Saygin C; Braley C; Wiechert AC; Karunanithi S; Crean-Tate K; Abdul-Karim FW; Michener CM; Rose PG; Lathia JD; Reizes O
J Ovarian Res; 2019 Nov; 12(1):112. PubMed ID: 31735168
[TBL] [Abstract][Full Text] [Related]
8. miR-589-5p inhibits MAP3K8 and suppresses CD90
Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
[TBL] [Abstract][Full Text] [Related]
9. Clonogenically Culturing and Expanding CD34+ Liver Cancer Stem Cells in Vitro.
Park SC; Zeng C; Tschudy-Seney B; Nguyen NT; Eun JR; Zhang Y; Ramsamooj R; Zhang Y; Zhao M; Theise ND; Zhou H; Zern MA; Duan Y
Stem Cells Dev; 2015 Jul; 24(13):1506-14. PubMed ID: 25867583
[TBL] [Abstract][Full Text] [Related]
10. Sorafenib suppresses extrahepatic metastasis de novo in hepatocellular carcinoma through inhibition of mesenchymal cancer stem cells characterized by the expression of CD90.
Yoshida M; Yamashita T; Okada H; Oishi N; Nio K; Hayashi T; Nomura Y; Hayashi T; Asahina Y; Ohwada M; Sunagozaka H; Takatori H; Colombo F; Porretti L; Honda M; Kaneko S
Sci Rep; 2017 Sep; 7(1):11292. PubMed ID: 28900199
[TBL] [Abstract][Full Text] [Related]
11. Sensitization of chemo-resistant human chronic myeloid leukemia stem-like cells to Hsp90 inhibitor by SIRT1 inhibition.
Kim HB; Lee SH; Um JH; Kim MJ; Hyun SK; Gong EJ; Oh WK; Kang CD; Kim SH
Int J Biol Sci; 2015; 11(8):923-34. PubMed ID: 26157347
[TBL] [Abstract][Full Text] [Related]
12. Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells.
Jia Q; Zhang X; Deng T; Gao J
Cell Reprogram; 2013 Apr; 15(2):143-50. PubMed ID: 23438193
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma.
Lingala S; Cui YY; Chen X; Ruebner BH; Qian XF; Zern MA; Wu J
Exp Mol Pathol; 2010 Aug; 89(1):27-35. PubMed ID: 20511115
[TBL] [Abstract][Full Text] [Related]
14. Distinct biological characterization of the CD44 and CD90 phenotypes of cancer stem cells in gastric cancer cell lines.
Shu X; Liu H; Pan Y; Sun L; Yu L; Sun L; Yang Z; Ran Y
Mol Cell Biochem; 2019 Sep; 459(1-2):35-47. PubMed ID: 31073886
[TBL] [Abstract][Full Text] [Related]
15. [Progress and prospects in cancer stem cell research for hepatocellular carcinoma].
Xu W; Cao L; Yin ZF
Ai Zheng; 2009 Sep; 28(9):1004-8. PubMed ID: 19728923
[TBL] [Abstract][Full Text] [Related]
16. Hepatic stem-like cells in hepatoblastoma: expression of cytokeratin 7, albumin and oval cell associated antigens detected by OV-1 and OV-6.
Ruck P; Xiao JC; Pietsch T; Von Schweinitz D; Kaiserling E
Histopathology; 1997 Oct; 31(4):324-9. PubMed ID: 9363447
[TBL] [Abstract][Full Text] [Related]
17. CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays.
He J; Liu Y; Zhu T; Zhu J; Dimeco F; Vescovi AL; Heth JA; Muraszko KM; Fan X; Lubman DM
Mol Cell Proteomics; 2012 Jun; 11(6):M111.010744. PubMed ID: 22203689
[TBL] [Abstract][Full Text] [Related]
18. Phenotype plasticity rather than repopulation from CD90/CK14+ cancer stem cells leads to cisplatin resistance of urothelial carcinoma cell lines.
Skowron MA; Niegisch G; Fritz G; Arent T; van Roermund JG; Romano A; Albers P; Schulz WA; Hoffmann MJ
J Exp Clin Cancer Res; 2015 Nov; 34():144. PubMed ID: 26606927
[TBL] [Abstract][Full Text] [Related]
19. The SHH/Gli axis regulates CD90-mediated liver cancer stem cell function by activating the IL6/JAK2 pathway.
Zhang K; Che S; Pan C; Su Z; Zheng S; Yang S; Zhang H; Li W; Wang W; Liu J
J Cell Mol Med; 2018 Jul; 22(7):3679-3690. PubMed ID: 29722127
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cells and their potential implications for the treatment of solid tumors.
Grotenhuis BA; Wijnhoven BP; van Lanschot JJ
J Surg Oncol; 2012 Aug; 106(2):209-15. PubMed ID: 22371125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
